Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +12.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 401–450 of 627 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05366881	cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease(CAMPERR)	recruiting	—	7,000	Adela, IncINDUSTRY	1	Jan 20, 2026	clinicaltrials
NCT06625684	Key Longitudinal Associations With Risk and Glioblastoma Outcomes(Key LARGO)	recruiting	—	200	Duke UniversityOTHER	1	Jan 20, 2026